Medtech and healthcare reign supreme in Venture Kick Stage 1!
09.03.2018
Three Medtech and one healthcare startup will now pass on to stage 2, after having impressed the jury and walked away with CHF 10,000 each.
 The team from Clemedi
|
 |
 The team from DocsVisit
|
|
 The team from Positrigo (BPET)
|
|
 The team from Rapid Graft
|
|
Clemedi (UZH) Medtech
Clemedi introduces next-generation sequencing based in vitro diagnostics for infectious diseases. The spread of antibiotic resistance is a major challenge within the healthcare industry, which could be solved through better and faster diagnostics, thereby conserving antibiotics for the future. By combining next-generation sequencing and machine learning algorithms, the startup is developing a diagnostic tool that can identify all relevant pathogens and suggest the most effective antibiotic therapy to clinicians, all within 24 hours.
DocsVisit (University of St. Gallen) Healthcare
DocsVisit is a trusted platform for medical practitioners connecting doctors and patients for home visits. Patients make appointments conveniently online or by phone and are matched with a physician in their area, that has the expertise and availability required, while the working style allows doctors to plan their hours of work flexibly and focus on frontline patient care.
Positrigo BPET (ETH Zurich) Medtech
Positron Emission Tomography (PET) is the best imaging method to scan for biomarkers of neurodegenerative diseases such as Amyloid Beta in Alzheimer's Disease. However, current scanners are both prohibitively large and expensive. Positrigo proposes to develop a cost-effective and mobile brain PET to enable scanning for diseases of the brain at significantly lower costs than currently possible, while also enabling high-throughput early diagnosis and treatment monitoring.
Rapid Graft (ETH Zurich) Medtech
Modern treatment methods for chronic wounds and scars require small skin grafts. Cells for autologous tissue engineering are also harvested from such. Due to the novelty of this need there is a lack of appropriate tools to take small skin grafts, in particular for tools that can be used in a dermatologist's office. Rapid Graft is developing a medical device optimized for cutting small skin grafts, enabling the production of grafts without requiring a specialist intervention, and all while reducing the risk of infection and scarring for the patient.
Clemedi introduces next-generation sequencing based in vitro diagnostics for infectious diseases. The spread of antibiotic resistance is a major challenge within the healthcare industry, which could be solved through better and faster diagnostics, thereby conserving antibiotics for the future. By combining next-generation sequencing and machine learning algorithms, the startup is developing a diagnostic tool that can identify all relevant pathogens and suggest the most effective antibiotic therapy to clinicians, all within 24 hours.
DocsVisit (University of St. Gallen) Healthcare
DocsVisit is a trusted platform for medical practitioners connecting doctors and patients for home visits. Patients make appointments conveniently online or by phone and are matched with a physician in their area, that has the expertise and availability required, while the working style allows doctors to plan their hours of work flexibly and focus on frontline patient care.
Positrigo BPET (ETH Zurich) Medtech
Positron Emission Tomography (PET) is the best imaging method to scan for biomarkers of neurodegenerative diseases such as Amyloid Beta in Alzheimer's Disease. However, current scanners are both prohibitively large and expensive. Positrigo proposes to develop a cost-effective and mobile brain PET to enable scanning for diseases of the brain at significantly lower costs than currently possible, while also enabling high-throughput early diagnosis and treatment monitoring.
Rapid Graft (ETH Zurich) Medtech
Modern treatment methods for chronic wounds and scars require small skin grafts. Cells for autologous tissue engineering are also harvested from such. Due to the novelty of this need there is a lack of appropriate tools to take small skin grafts, in particular for tools that can be used in a dermatologist's office. Rapid Graft is developing a medical device optimized for cutting small skin grafts, enabling the production of grafts without requiring a specialist intervention, and all while reducing the risk of infection and scarring for the patient.